APLASIA RAS HOMOLOGOUS MEMBER I GENE
AND DEVELOPMENT OF GLIAL TUMORS
Yakut S1, Tuncer MR2,* Berker M3, Goksu E2, Gurer I4, Ozes ON1, Luleci G1, Karauzum SB1
*Corresponding Author: Sibel Berker Karauzum, Department of Medical Biology and Genetics, Faculty
of Medicine, Akdeniz University Antalya, Turkey; Tel.: +90 242 2496971; Fax: +90 242 2274482; E-mail:
sibelkarauzum@akdeniz.edu.tr
page: 37
|
|
REFERENCES
1. Kunzang C, Parthaprasad C, Subrata S. Molecular
pathways of glial tumorigenesis. Curr Sci. 2002;
82(6): 648-654.
2. McCormick F. Signaling networks that cause cancer.
Trends Cell Biol. 1999; 9(12): 53-56.
3. Kitange GJ, Templeton KL, Jenkins RB. Recent advances
in the molecular genetics of primary gliomas.
Curr Opin Oncol. 2003; 15(3):197-203.
4. Maher EA, Furnari FB, Bachoo RM, Rowitch DH,
Louis DN, Cavenee WK, DePinho RA. Malignant
glioma: genetics and biology of a grave matter.
Genes Dev. 2001; 15(11): 1311-1333.
5. Nigro JM, Takahashi MA, Ginzinger DG, Law M,
Passe S, Jenkins RB, Aldape K. Detection of 1p and 19q
loss in oligodendroglioma by quantitative micro satellite
analysis, a real-time quantitative polymerase chain
reaction assay. Am J Pathol. 2001; 158(4): 1253-1262.
6. Schmidt MC, Antweiler S, Urban N, Mueller W,
Kuklik A, Meyer-Puttlitz B, Wiestler OD, Louis DN,
Fimmers R, von Deimling A. Impact of genotype
and morphology on the prognosis of glioblastoma. J
Neuropathol Exp Neurol. 2002; 61(4): 321-328.
7. Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y, Cuevas
B, Kuo WL, Gray JW, Siciliano M, Mills GB, Bast
RC Jr. NOEY2 (ARHI), an imprinted putative tumor
suppressor genei n ovarian and breast carcinomas.
Proc Natl Acad Sci USA. 1999; 96(1): 214-219.
8. Luo RZ, Peng H, Xu F, Bao J, Pang Y, Pershad R,
Issa JP, Liao WS, Bast RC Jr, Yu Y. Genomic structure
and promoter characterization of an imprinted
tumor suppressor gene ARHI. Biochimica Biophysica
Acta. 2001; 1519(3): 216-222.
9. Luo RZ, Fang X, Marquez R, Liu SY, Mills GB, Liao
WS, Yu Y, Bast RC. ARHI is a Ras-related small Gprotein
with a novel N-terminal extension that inhibits
growth of ovarian and breast cancers. Oncogene.
2003; 22(19): 2897-2909.
10. Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M,
Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP,
Bast RC Jr, Yu Y. Aberrant methylation and silencing
of ARHI, an imprinted tumor suppressor gene in
which the function is lost in breast cancers. Cancer
Res. 2003; 63(14): 4174-4180.
11. Weber F, Aldred MA, Morrison CD, Plass C, Frilling
A, Broelsch CE, Waite KA, Eng C. Silencing of the
maternally imprinted tumor suppressor ARHI contributes
to follicular thyroid carcinogenesis. J Clin
Endocrinol Metab. 2005; 90(2): 1149-1155.
12. Dalai I, Missiaglia E, Barbi S, Butturini G, Doglioni C,
Falconi M, Scarpa A. Low expression of ARHI is associated
with shorter progression-free survival in pancreatic
endocrine tumors. Neoplasia. 2007; 9(3): 181-183.
13 Peng H, Xu F, Pershad R, Hunt KK, Frazier ML,
Berchuck A, Gray JW, Hogg D, Bast RC Jr, Yu Y.
ARHI is the center of allelic deletion on chromosome
1p31 in ovarian and breast cancers. Int J Cancer.
2000; 86(5): 690-694.
14. Riemenschneider MJ, Reifenberger J, Reifenberger
G. Frequent biallelic inactivation and transcriptional
silencing of the DIRAS3 gene at 1p31 in oligodendroglial
tumors with 1p loss. Int J Cancer. 2008;
122(11): 2503-2510.
15. Miller SA, Dykes DD, Polesky HF. A simple salting
out procedure for extracting DNA from human nucleated
cells. Nucleic Acids Res. 1988; 16(3): 1215.
16. Zhenggang X, Peter WL. COBRA: a sensitive and
quantitative DNA methylation assay. Nucleic Acids
Res. 1997; 25(12): 2532-2534.
17. Yu Y, Fujii S, Yuan J, Luo RZ, Wang L, Bao J, Kadota
M, Oshimura M, Dent SR, Issa JP, Bast RC Jr.
Epigenetic regulation of ARHI in breast and ovarian
cancer cells. Ann NY Acad Sci. 2003; 983: 268-277.
|
|
|
|
 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
|
